Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation

Oncotarget

Volumn 8, Issue 2, 2017, Pages 3509-3518

  Sun, Yong ^a   Cheng, Hongyu ^a   Wang, Guangjun ^a   Yu, Guojun ^a   Zhang, Dawei ^a   Wang, Yibing ^a   Fan, Wei ^a   Yang, Weixi ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Competitive endogenous RNA; ITGB1; MALAT1; Melanoma; miR 183

Indexed keywords

BETA1 INTEGRIN; COMPETITIVE ENDOGENOUS RNA; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA MALAT1; MICRORNA; MICRORNA 183; RNA; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN; MIRN183 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; OVERALL SURVIVAL; RNA BINDING; RNA PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CELL MOTION; CELL PROLIFERATION; DISEASE MODEL; DRUG SCREENING; GENETICS; METABOLISM; MORTALITY; PROGNOSIS; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN BETA1; MELANOMA; MICE; MICRORNAS; MODELS, BIOLOGICAL; PROGNOSIS; RNA INTERFERENCE; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85009819037     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.13862     Document Type: Article

References (27)

1. Erdmann F, Lortet-Tieulent J, Schuz J, Zeeb H, Greinert R, Breitbart EW, Bray F. International trends in the incidence of malignant melanoma 1953-2008are recent generations at higher or lower risk? International journal of cancer. 2013; 132:385-400
2. Satyamoorthy K, Herlyn M. Cellular and molecular biology of human melanoma. Cancer biology & therapy. 2002; 1:14-17
3. Zubrilov I, Sagi-Assif O, Izraely S, Meshel T, Ben-Menahem S, Ginat R, Pasmanik-Chor M, Nahmias C, Couraud PO, Hoon DS, Witz IP. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells. Cancer letters. 2015; 361:86-96
4. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews Genetics. 2004; 5:522-531
5. Kunz M. MicroRNAs in melanoma biology. Advances in experimental medicine and biology. 2013; 774:103-120
6. Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jaafari MR, Mirzaei HR, Hassanian SM, Avan A. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. European journal of cancer. 2016; 53:25-32
7. Chen J, Gu L, Ni J, Hu P, Hu K, Shi YL. MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells. BioMed research international. 2015; 2015:340218
8. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer letters. 2013; 339:159-166
9. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136:629-641
10. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011; 146:353-358
11. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell. 2011; 147:358-369
12. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH, De W, Wang KM, Wang ZX. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Molecular cancer. 2014; 13:92
13. Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian K, Xie Y, Wang S, Xu N, Wang Y, Qi C. miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation. Oncotarget. 2016; 7:16205-16216. doi: 10.18632/oncotarget.7578
14. Guo S, Chen W, Luo Y, Ren F, Zhong T, Rong M, Dang Y, Feng Z, Chen G. Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients. International journal of clinical and experimental pathology. 2015; 8:5395-5402
15. Tian X, Xu G. Clinical value of lncRNA MALAT1 as a prognostic marker in human cancer: systematic review and meta-analysis. BMJ open. 2015; 5:e008653
16. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. The Journal of biological chemistry. 2010; 285:5461-5471
17. Alshalalfa M. MicroRNA Response Elements-Mediated miRNA-miRNA Interactions in Prostate Cancer. Advances in bioinformatics. 2012; 2012:839837
18. Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505:344-352
19. Kartha RV, Subramanian S. Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Frontiers in genetics. 2014; 5:8
20. Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, Quan ZW. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell death & disease. 2015; 6:e1583
21. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L, Lu L, Liu C, Yi JS, Zhang H, Min W, Bennett AM, Gregory RI, Ding Y, Huang Y. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Molecular cell. 2013; 52:101-112
22. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic acids research. 2013; 41:4976-4987
23. Tee AE, Liu B, Song R, Li J, Pasquier E, Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, Fletcher JI, Dinger ME, Liu T. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget. 2016; 7:8663-8675. doi: 10.18632/oncotarget.6675
24. Yoshimoto R, Mayeda A, Yoshida M, Nakagawa S. MALAT1 long non-coding RNA in cancer. Biochimica et biophysica acta. 2016; 1859:192-199
25. Luan W, Li L, Shi Y, Bu X, Xia Y, Wang J, Djangmah HS, Liu X, You Y and Xu B. Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. Oncotarget. 2016. doi: 10.18632/oncotarget.11564. [Epub ahead of print]
26. Huang C, Park CC, Hilsenbeck SG, Ward R, Rimawi MF, Wang YC, Shou J, Bissell MJ, Osborne CK, Schiff R. beta1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib. Breast cancer research. 2011; 13:R84
27. Lau MT, So WK and Leung PC. Integrin beta1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. Cancer letters. 2012; 320:198-204